Arum Therapeutics

Novel anticancer and antiviral therapeutics overcoming drug resistance

Seoul, South Korea · Founded 2019 · $5.8M raised

Headquarters
Seoul
Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$5.8M
Last Round
$5.8M Series AApr 2021
Rounds
1

About

Arum Therapeutics Inc. is a South Korean biopharmaceutical company focused on developing novel synthetic therapeutics targeting cancer and respiratory rare diseases. Founded in 2019 and headquartered in Seoul, the company is advancing pipeline programs in anticancer agents designed to overcome drug resistance, anticancer immunotherapy combinations, and target-based antiviral agents for conditions including asthma and COPD. Arum Therapeutics applies a target-based drug discovery approach, combining synthetic chemistry and molecular biology expertise to build a diversified oncology and rare disease pipeline aimed at addressing unmet medical needs in markets underserved by existing therapies.

Summary

Arum Therapeutics is a Biotech company based in Seoul, South Korea, founded in 2019. It has raised $5.8M in total across 1 round, most recently a $5.8M Series A round in Apr 2021. Investors include SBI Investment.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2021
$5.8M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Arum Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/arum-therapeutics"><img src="https://indexed.vc/api/badge/company/arum-therapeutics" alt="Arum Therapeutics on Indexed.vc" width="260" height="76" /></a>